1. Participants of the European Rating Aggression Group (ERAG) including Schneider, B. Social dysfunction and aggression scale (SDAS-21) in generalized aggression and in aggressive attacks, a validity and reliability study. Int J Methods Psychiatr Res 1992; 2: 15-29 2. Fritze J, Schneider B, Lanczik M. Vaskuläre Risikofaktoren bei affektiven Psychosen. [Vascular risk factors in affective psychoses]. Krankenhauspsychiatrie 1993; 4: 14-18 3. Fritze J, Schneider B, Lanczik M. Autoaggressive behaviour and cholesterol. Neuropsychobiology. 1992; 26(4):180-1 4. Gerbaldo H, Helisch A, Schneider B, Philipp M, Benkert O. Subtyps of negative symptoms: the primary subtyps in schizophrenic and non-schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiat 1994; 18: 311-320 5. Fritze J, Beneke M, Lanczik M, Schneider B, Walden J. Carbamazepine as adjunct or alternative to lithium in the prophylaxis of recurrent affective disorders. Pharmacopsychiatry 1994; 27: 181-185 6. Weber B, Petersen WK, Schneider B, Simminger D, Fritze J, Maurer K. Selbstbeurteilung und Verlauf wahn-indizierender dysfunktionaler Kognitionen bei stationär behandelten depressiven Patienten. Nervenarzt 1998; 69: 592-599 7. Weber B, Fritze J, Schneider B, Simminger D, Maurer K. Computerized self assessment in psychiatric inpatients. Acceptability, feasibility and influence of computer attitude. Acta Psychiatr Scand 1998; 98: 140-145 8. Schneider B, Philipp M, Müller MJ, Benkert O. Mortalität bei psychiatrischen Erkrankungen - Ergebnisse einer 5-Jahres-Katamnese. I. Unnatürlicher Tod. Suizidprophylaxe 1999; 26: 6-17 9. Schneider B, Philipp M, Müller MJ, Benkert O. Mortalität bei psychiatrischen Erkrankungen - Ergebnisse einer 5-Jahres-Katamnese. II. Natürlicher Tod. Suizidprophylaxe 1999; 26: 18-26 10. Markowitsch HJ, Kessler J, Russ MO, Frölich L, Schneider B, Maurer K. Mnestic block syndrome. Cortex 1999; 35: 219-230 11. Schneider B, Weber B, Frensch A, Stein J, Fritze J. Vitamin D in schizophrenia, major depression and alcoholism. J Neural Transm 2000; 107: 839-842 12. Schneider B, Müller JM, Philipp M. Mortality in affective disorders. J Affect Disord 2001; 65: 263-274 13. Schneider B, Philipp M, Müller MJ. Psychopathological predictors of suicide in patients with major depression during a 5-year follow-up. Eur Psychiatry 2001; 16: 283-288 14. Weber B, Fritze J, Schneider B, Kühner T, Maurer K. Bias in computerized neuropsychological assessment of depressive disorders caused by computer attitude. Acta Psychiatr Scand 2002; 105:126-130
15. Schneider B, Weber B, Maurer K, Frölich L. Problematik bei der Beurteilung depressiver Symptome Demenzkranker. Psychiatr Prax 2002; 29: 76-82 16. Weber B, Schneider B, Fritze J, Gille B, Hornung S, Kühner T, Maurer K. Acceptance of computerized compared to paper- and – pencil assessment in psychiatric inpatients. Comput Hum Behav 2003; 19: 81-93 17. Schneider B, Weigmann H, Hiemke C, Weber B, Fritze J. Reduction of clozapine-induced hypersalivation by pirenzepine is safe. Pharmacopsychiatry 2004; 37: 43-45 18. Schneider B, Maurer K, Sargk D, Heiskel H, Weber B, Frölich L, Georgi K, Fritze J, Seidler A. Concordance of DSM-IV Axis I and II diagnoses by personal and informant’s Interview. Psychiatry Res 2004; 127: 121-136 19. Schneider B, Schnabel A, Sargk D, Maurer K, Weber B, Wetterling T. Detection of alcohol consumption in suicides. Eur Arch Psychiatry Clin Neurosci 2005; 255: 1-5 20. Schneider B, Schnabel A, Weber B, Frölich L, Maurer K, Wetterling T. Nicotine use in suicides: a case-control study. Eur Psychiatry 2005; 20: 129-136 21. Schneider B, Bartusch B, Schnabel A, Fritze J. Achse I-Störungen als Risikofaktoren für Suizid in Abhängigkeit von Alter und Geschlecht. Psychiatr Prax 2005; 32: 185-194 22. Schneider B, Wetterling T, Sargk D, Schneider F, Schnabel A, Maurer K, Fritze J. Axis I-disorders and personality disorders as risk factors for suicide. Eur Arch Psychiatry Clin Neurosci 2006; 256: 17-27 23. Schneider B, Georgi K, Weber B, Schnabel A, Ackermann H, Wetterling T. Risikofaktoren für Suizid bei Störungen im Zusammenhang mit psychotropen Substanzen. Psychiatr Prax 2006; 33: 81-87 24. Kõlves K, Värnik A, Schneider B, Fritze J, Allik J. Recent life events and suicide: a case-control study in Tallinn and Frankfurt. Soc Sci Med 2006; 62: 2887-2896 25. Wetterling T, Schneider B, Weber B. Dyslipidämie bei langjähriger neuroleptischer Behandlung [Dyslipidemia and schizophrenia]. Psychiatr Prax 2007; 34: 223-229 26. Wetterling T, Schneider B, Weber B. Blutzuckerwerte bei chronisch schizophrenen Patienten unter antipsychotischer Behandlung [Blood glucose in chronic schizophrenic patients treated with antipsychotics]. Psychiatr Prax 2007; 34:76-80 27. Wetterling T, Weber B, Depfenhart M, Schneider B, Junghanns K. Development of a Rating Scale that allows to predict the Severity of Alcohol Withdrawal Syndrome. Alcohol alcohol 2006; 41: 611-615 28. Schneider B, Kõlves K, Blettner M, Wetterling T, Schnabel A, Värnik A. Substance use disorders as risk factors for suicide in an Eastern and a Central European city. Psychiatry Res. 2009; 165: 263-272 29. Weber B, Schneider B, Hornung S, Wetterling T, Fritze J. Computer attitude –measurable in psychiatric inpatients? Comput Hum Behav 2008; 24: 1741-1752
30. Giegling I, Rujescu D, Mandelli L, Schneider B, Hartmann AM, Schnabel A, Maurer K, De Ronchi D, Möller HJ, Serretti A. Tachykinin receptor 1 variants associated with aggression in suicidal behavior. Am J Med Genet B Neuropsychiatr Genet 2007; 144: 757-761 31. Serretti A, Mandelli L, Giegling I, Schneider B, Hartmann AM, Schnabel A, Maurer K, Möller HJ, Rujescu D. HTR2C and HTR1A gene variants in German and Italian suicide attempters and completers. Am J Med Genet B Neuropsychiatr Genet 2007; 144: 291-299 32. Rujescu D, Giegling I, Mandelli L, Schneider B, Hartmann AM, Schnabel A, Maurer K, Möller HJ, Serretti A. NOS-I and -III gene variants are differentially associated with facets of suicidal behavior and aggression-related traits. Am J Med Genet B Neuropsychiatr Genet 2008; 147: 42-48 33. Gietl A, Giegling I, Hartmann AM, Schneider B, Schnabel A, Maurer K, Möller HJ, Rujescu D. ABCG1 gene variants in suicidal behavior and aggression-related traits. Eur Neuropsychopharmacol 2007; 17: 410-416 34. Schneider B, Schnabel A, Wetterling T, Bartusch B, Weber B, Georgi K. How do personality disorders modify suicide risk? J Personal Disord 2008; 22: 233-245 35. Thalmeier A, Dickmann M, Giegling I, Schneider B, Hartmann AM, Maurer K, Schnabel A, Kauert G, Möller HJ, Rujescu D. Gene expression profiling of post mortem orbitofrontal cortex in violent suicide victims. Int J Neuropsychopharmacol 2008; 11: 217-228 36. Tonelli LH, Stiller J, Rujescu D, Giegling I, Schneider B, Maurer K, Schnabel A, Möller H-J, Postolache TT. Elevated Cytokine Expression in the Orbitofrontal cortex of victims of suicide. Acta Psychiatr Scand 2008; 117: 198-206 37. Giegling I, Moreno-De-Luca D, Rujescu D, Schneider B, Hartmann AM, Schnabel A, Maurer K, Möller HJ, Serretti A. Dopa decarboxylase and tyrosine hydroxylase gene variants in suicidal behavior. Am J Med Genet B Neuropsychiatr Genet. 2008; 147: 308-315 38. Schneider B, Wetterling T, Georgi K, Bartusch B, Schnabel A, Blettner M. Smoking differently modifies suicide risk of affective disorders, substance use disorders, and social factors. J Affect Disord 2009; 112: 165-173 39. Giegling I, Rujescu D, Mandelli L, Schneider B, Hartmann AM, Schnabel A, Maurer K, De Ronchi D, Möller HJ, Serretti A. Estrogen receptor gene 1 variants are not associated with suicidal behavior. Psychiatry Res 2008; 160: 1-7 40. Klempan T, Rujescu D, Merette C, Himmelman C, Sequeira A, Canetti L, Fiori I, Schneider B, Bureau A, Turecki G. Profiling Brain Expression of the Spermidine/Spermine N1-Acetyltransferase 1 (1) Gene in Suicide" has been accepted for publication in Neuropsychiatric Genetics. Am J Med Genet B Neuropsychiatr Genet. 2009; 150: 934-943 41. Schneider B, Georgi K. Zur Frage der Verwendbarkeit des Buss-Durkee Aggressionsfragebogens und der Barratt Impulsiveness Skala im Rahmen der Psychologischen Autopsie. Suizidprophylaxe 2009; 139: 176-180
42. Müller B, Georgi K, Schnabel A, Schneider B. Does sport have a protective effect against suicide? Epidemiologia e Psichiatria Sociale 2009; 18: 331-335 43. Giegling I, Chiesa A, Mandelli L, Gibiino S, Hartmann AM, Möller HJ, Schneider B, Schnabel A, Maurer K, De Ronchi D, Rujescu D, Serretti A. Influence of neuronal cell adhesion molecule (NCAM1) variants on suicidal behaviour and correlated traits. Psychiatry Res 2010; 179: 222-225 44. Schneider B, Georgi K, Fritze J, Grebner K. Finden suizidale Suchtkranke Hilfsangebote im Internet? Nervenarzt 2011; 82: 859-865 45. Schneider B, Baumert J, Schneider A, Marten-Mittag B, Meisinger C, Erazo N, Hammer GP, Ladwig KH. The effect of risky alcohol use and smoking on suicide risk.Findings from the German MONICA/KORA-Augsburg Cohort Study. Soc Psych Psych Epid 2011; 46: 1127-1132 46. Schneider B, Grebner K, Schnabel A, Georgi K. Is survivors’ emotional response dependent on the consequences of the suicide and the received support? Crisis 2011; 32:186-193 47. Schneider B, Grebner K, Schnabel A, Georgi K. Do suicides’ characteristics influence survivors’ emotions? Suicide Life Threat Behav 2011; 41:117-125 48. Schneider B, Grebner K, Schnabel A, Hampel H, Georgi K, Seidler A. H Impact of employment status and work-related factors on risk of completed suicide. A case -control psychological autopsy study. Psychiatr Res 2011; 190: 265-270 49. Wetterling T, Schneider B. Medikamentenmißbrauch bei älteren psychiatrischen Patienten. [Prescription Drug Abuse in Elderly Psychiatric Patients.] Psychiatr Prax. 2012 Jun 11. [Epub ahead of print] press)
Psychiatrists, Children and Drug Industry’s Role - New York Times May 10, 2007 Psychiatrists, Children and Drug Industry’s Role By GARDINER HARRIS, BENEDICT CAREY and JANET ROBERTS When Anya Bailey developed an eating disorder after her 12th birthday, her mother took her to a psychiatrist at the University of Minnesota who prescribed a powerful antipsychotic drug called Rispe